VolitionRx Limited (NYSE:VNRX) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Scott Powell – Executive Vice President-Investor Relations Cameron Reynolds – President and Group Chief Executive Officer Terig Hughes – Group Chief Financial Officer Tom Butera – Chief Executive Officer-Volition Veterinary Diagnostics Development LLC Conference Call Participants Bruce Jackson – Benchmark Constantine Davides – E.F. Hutton Steven Ralston – Zacks David Westenberg – Piper Sandler Jim ...

© © Corporate Deck March 2023 Property of Volition 2023 Slide 1 Forward Looking Statements and Disclaimer Statements in this document may be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that concern matters that involve risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in the forward-looking statements. Words such as " ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission File Number: 001-36833 VOLITIONRX LIMITED (Exact name of registrant as specified in its charter) Delaware 91-1949078 (State or other jurisdicti ...